SCHEMBL20879031

SCHEMBL20879031

CC(C)c1cc(C(=N)N(C(N)=O)c2ccc3c(ccn3CCNC(=O)CCCCCN)c2)c(O)cc1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 12/20 0.39
HDAC1 Q13547 12/20 0.39
HDAC8 Q9BY41 12/20 0.39
HDAC6 Q9UBN7 12/20 0.39
HSP90AA1 P07900 12/20 0.39
HDAC2 Q92769 11/20 0.39
HDAC11 Q96DB2 11/20 0.39
HDAC5 Q9UQL6 11/20 0.39
HDAC7 Q8WUI4 10/20 0.39
HDAC10 Q969S8 10/20 0.39
ERBB2 P04626 1/20 0.37
MTNR1A P48039 2/20 0.36
MTNR1B P49286 2/20 0.36
TRAP1 Q12931 1/20 0.35
HDAC4 P56524 9/20 0.33
HDAC9 Q9UKV0 8/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20879118 0.91 MTNR1A (0.44) HDAC3HDAC1HDAC8HDAC6HSP90AA1
SCHEMBL20879038 0.86 ERBB2 (0.39) HDAC3HDAC1HDAC8HDAC6HSP90AA1
SCHEMBL15604263 0.86 ERBB2 (0.40) HDAC3HDAC1HDAC8HDAC6HSP90AA1
SCHEMBL20878879 0.83 ERBB2 (0.39) HDAC3HDAC1HDAC8HDAC6HSP90AA1
SCHEMBL18103365 0.83 THRA (0.39) HDAC3HDAC1HDAC8HDAC6HSP90AA1
SCHEMBL22667590 0.83 CA12 (0.42)
SCHEMBL20879039 0.82 TDP1 (0.43)
SCHEMBL19154279 0.81 ERBB2 (0.39) HSP90AA1ERBB2THRATHRB
SCHEMBL20879030 0.80 HSP90AA1 (0.38) HSP90AA1ERBB2
SCHEMBL22354738 0.79 HSP90AA1 (0.34) HSP90AA1ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3738594-A1 TARGETED THERAPEUTICS HAVING AN HSP90 LIGAND AS BINDING MOIETY Madrigal Pharmaceuticals, Inc. (US) 2020-11-18 EP disclosed
EP-3035938-B1 TARGETED THERAPEUTICS MADRIGAL PHARMACEUTICALS INC (US) 2020-08-19 EP disclosed
EP-3466416-A2 A BINDING MOIETY-DRUG CONJUGATE COMPRISING A HSP90 BINDING MOIETY AND A CYTOTOXIC EFFECTOR MOIETY Madrigal Pharmaceuticals, Inc. (US) 2019-04-10 EP disclosed